CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS

被引:66
作者
Dittel, Bonnie N. [1 ]
机构
[1] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53201 USA
关键词
CD4 T cell; central nervous system; experimental autoimmune encephalomyelitis; inflammation; multiple sclerosis;
D O I
10.1016/j.bbi.2007.11.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The regulation of the inflammatory response is often viewed as very complex with many cellular players. The type of immune response generated is dependent upon the nature of the immune stimulation. In autoimmunity, one of the most important players is the CD4 T cell. The CD4 T cell lineage consists of a number of phenotypically and functionally distinct subsets. The unique functions of CD4 T cells are often mediated by soluble factors, which shape the nature of the immune response. In a T cell-mediated autoimmune response, such as in multiple sclerosis (MS), the CD4 T cell is thought to orchestrate and drive the immune response resulting in inflammation within the central nervous system (CNS). The extent of the inflammation must be tightly controlled or permanent tissue damage will occur. In MS, progressive debilitating disease is thought to be due to such damage. In addition to promoting inflammation, the CD4 T cell lineage also has the capacity to prevent and downmodulate inflammation. This is accomplished by specific CD4 T regulatory (Treg) cells and other regulatory feedback mechanisms. Thus although the complexity of the immune system is often viewed as too complicated for a nonimmunologist to fully understand, there are patterns that emerge that make the system clearer. One such pattern is the balance that the immune system must always maintain. A weak or slow immune response to a pathogen can lead to sickness and even death, while a too robust or uncontrolled immune response can lead to tissue damage, and for autoimmune diseases, ultimately death. How CD4 T cells maintain this balance will be discussed in the context of the CNS autoimmune disease MS. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 77 条
[1]
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[2]
Anderson TJ, 1998, J COMP NEUROL, V394, P506, DOI 10.1002/(SICI)1096-9861(19980518)394:4<506::AID-CNE8>3.0.CO
[3]
2-5
[4]
The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system [J].
Becher, B ;
Durell, BG ;
Miga, AV ;
Hickey, WF ;
Noelle, RJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (08) :967-974
[5]
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[6]
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease [J].
Bjartmar, C ;
Wujek, JR ;
Trapp, BD .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (02) :165-171
[7]
Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis [J].
Carson, MJ .
GLIA, 2002, 40 (02) :218-231
[8]
Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis [J].
Chang, TT ;
Jabs, C ;
Sobel, RA ;
Kuchroo, VK ;
Sharpe, AH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) :733-740
[9]
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[10]
Dittel BN, 1999, J IMMUNOL, V162, P6392